HTI44 Kalinin MN, Khasanova DR, Ibatullin MM. The hemorrhagic transformation index score: a prediction tool in middle cerebral artery ischemic stroke. BMC Neurol. 2017 Sep 7;17(1):177. https://doi.org/10.1186/s12883-017-0958-3 https://doi.org/10.1186/s12883-017-0958-...
|
ASPECTS, Atrial Fibrillation on ECG, NIHSS, INR (1.26–1.82 and ≤1.25) and hyperdense middle cerebral artery sign |
Any |
ECASS I |
CT only |
7–14 days |
HAT99 Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008 Oct;71(18):1417-23. https://doi.org/10.1212/01.wnl.0000330297.58334.dd https://doi.org/10.1212/01.wnl.000033029...
|
Diabetes mellitus or blood glucose on admission (>200 mg/dL), NIHSS (15–19 or >19) and presence of early visible hypodensity on initial head CT scan (regarding involvement of 1/3 of MCA area) |
SHT |
NINDS |
CT or MRI |
24–48 h |
SEDAN1010 Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012 Jan;71:634-41. https://doi.org/10.1161/STROKEAHA.113.003806 https://doi.org/10.1161/STROKEAHA.113.00...
|
Age (>75 years), NIHSS (≥10), early infarct signs on initial CT scan, hyperdense middle cerebral artery sign and blood glucose on admission (145-216 and >216 mg/dL) |
SHT |
ECASS II |
CT or MRI |
24 h |
iSCORE1111 Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using age and NIH Stroke Scale: SPAN-100. Neurology. 2013 Jan;80(1):21-8. https://doi.org/10.1212/WNL.0b013e31827b1ace https://doi.org/10.1212/WNL.0b013e31827b...
|
Age, atrial fibrillation on ECG, chronic heart failure, NIHSS/Canadian neurological scale, preadmission disability, renal dialysis or cancer, male sex, clinical stroke subtype (lacunar or non-lacunar) and blood glucose on admission (≥135 mg/dL) |
Any |
ECASS II and NINDS |
NA |
NA |
SPAN-1003030 Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012 Feb;43(5):1315-22. https://doi.org/10.1161/STROKEAHA.111.646265 https://doi.org/10.1161/STROKEAHA.111.64...
|
Age and NIHSS on admission |
Any |
NINDS |
CT only |
36 h |
HeRS3131 Marsh EB, Llinas RH, Schneider AL, Hillis AE, Lawrence E, Dziedzic P, et al. Predicting hemorrhagic transformation of acute ischemic stroke. Medicine (Baltimore). 2016 Jan;95(2):e2430. https://doi.org/10.1097/MD.0000000000002430 https://doi.org/10.1097/MD.0000000000002...
|
Age, infarct volume and glomerular filtration rate |
Any |
ECASS II |
MRI only |
Seven days |
SITS-SICH3232 Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012 Jun;43(6):1524-31. https://doi.org/10.1161/STROKEAHA.111.644815 https://doi.org/10.1161/STROKEAHA.111.64...
|
Age (≥72 years), antiplatelet (aspirin alone or aspirin + clopidogrel), history of arterial hypertension, NIHSS (7–12 and ≥13), stroke onset to treatment time (≥180 min), SBP (≥146 mmHg), weight (≥95 kg) and blood glucose on admission (≥180 mg/dL) |
SHT |
SITS-MOST |
CT or MRI |
22–36 h |
MSS3333 Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):331-3. https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.03.012 https://doi.org/10.1016/j.jstrokecerebro...
|
Age (≥60 years), NIHSS (≥10), blood glucose (>150 mg/dl) and platelet count less than 150,000/mm3
|
Any |
NINDS |
CT only |
Up to 36 h |
GRASPS3434 Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012 Sep;43(9):2293-9. https://doi.org/10.1161/STROKEAHA.112.660415 https://doi.org/10.1161/STROKEAHA.112.66...
|
Age, ethnicity (Asian or non-Asian), male sex, NIHSS, SBP and blood glucose on admission |
SHT |
NINDS |
CT or MRI |
Up to 36 h |
THRIVE3535 Flint AC, Cullen SP, Faigeles BS, Rao VA. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. AJNR Am J Neuroradiol. 2010 Aug;31(7):1192-6. https://doi.org/10.3174/ajnr.A2050 https://doi.org/10.3174/ajnr.A2050...
|
Age (≤59, 60–79, ≥80), NIHSS on admission (≤10, 11–20, ≥21) and comorbidities (arterial hypertension, diabetes mellitus or atrial fibrillation) |
SHT or intraparenchymal hematoma type 2 |
NINDS and SITS |
CT only |
72 h |